T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA

This adverse event was reported 20 times

T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TEBENTAFUSP 1 0.0017
1 MOSUNETUZUMAB 1 0.0009
2 GLOFITAMAB 1 0.0004
3 AMLODIPINE AND ATORVASTATIN 1 0.0002
4 ALEMTUZUMAB 2 0.0001
5 CLADRIBINE 1 0.0001
6 INSULIN GLULISINE 1 0.0001
7 BLINATUMOMAB 1 0.0001
8 EPOETIN ALFA 1 0.0001
9 VELPATASVIR AND SOFOSBUVIR 1 0.0001
See all drugs enriched for association with T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA